Related Experiment Video
Updated: Aug 13, 2026
10:35
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Intravenous immunoglobulin and fibrosis
Vered Molina1, Miri Blank, Yehuda Shoenfeld
1Department of Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Clinical Reviews in Allergy & Immunology
|January 5, 2006
Summary
Fibrosis, characterized by scar tissue and extracellular matrix overproduction, affects organs like the liver and lungs. Intravenous immunoglobulin shows promise in treating fibrotic diseases, improving patient quality of life.
Area of Science:
- Pathology
- Immunology
- Biochemistry
Background:
- Fibrosis involves excessive extracellular matrix deposition in response to tissue damage.
- It underlies various conditions including liver cirrhosis, pulmonary fibrosis, and scleroderma.
- Current treatments primarily use anti-inflammatory and immunosuppressive agents with limited efficacy.
Purpose of the Study:
- To review the molecular mechanisms of fibrosis.
- To evaluate the potential of intravenous immunoglobulin (IVIG) as an antifibrotic therapy.
Main Methods:
- Review of literature on fibrotic processes and their molecular mediators.
- Analysis of existing data on IVIG's effects in fibrotic diseases.
Main Results:
- Key profibrotic factors include CD4+ T-cells, CD40 signaling, IL-4, TGF-β, and PDGF.
- Interferon-gamma is a major antifibrotic agent.
- No antifibrotic therapy has demonstrated clinical efficacy to date.
Conclusions:
- Fibrosis is a complex process involving specific molecular pathways.
- Intravenous immunoglobulin exhibits a favorable safety profile and ameliorating effects in fibrotic conditions.
- IVIG represents a potential therapeutic option for fibrotic diseases, enhancing quality of life.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...